Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: July 2023

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Set to be Used in Multi-Billion Dollar Markets; On Track to have 2023 as Best Year Yet

Posted on July 26, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is out on an ambitious move to address conditions with high unmet needs. This focus has allowed them to make strides in the potential treatment of conditions such as … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

Posted on July 26, 2023 by MissionIR

According to Goldman Sachs Research, the global pharmaceutical industry is sitting on about $700 billion in dealmaking firepower, expected to fuel M&A-driven growth as companies look to revamp their intellectual property portfolio as their existing patents expire (https://ibn.fm/7VNq6). Flush with … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW), Partners Launch Proven Breakthrough Hair-Booster System in India

Posted on July 25, 2023 by MissionIR

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, in partnership with its regional distributors, has launched Cosmofix MinoxiBoost in India. JUPW’s distributors are Sanpellegrino Cosmetics Pvt Ltd and Cosmofix Technovation Pvt Ltd, which have exclusive distribution … Continue reading →

Posted in Jupiter Wellness Inc. JUPW | Leave a comment

MissionIRNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Announces Financial Transactions to Secure Growth Capital, Retire Debt

Posted on July 25, 2023 by MissionIR

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” has completed a series of transactions resulting in $1.5 million in growth capital for the company; the funds also allow the company to … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) CEO Featured in C-Level Interview with BestGrowthStocks.Com

Posted on July 25, 2023 by MissionIR

FingerMotion’s (NASDAQ: FNGR) CEO Martin J. Shen was featured in an interview with Best Growth Stocks, a leading independent equity research and corporate access firm focused on small and mid-cap growth companies. During the interview, Best Growth Stocks Senior Editor … Continue reading →

Posted in FingerMotion Inc. FNGR | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Accelerates Commercial Quantum Adoption As Business and Government Interest in Quantum Computing Grows

Posted on July 25, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and services, continues to provide customers clear value via practical quantum and quantum-hybrid applications that solve real-world problems in the areas of logistics, artificial intelligence, materials sciences, drug … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Reports Promising Results from Texmont Project Amid Forecast of Growing Demand

Posted on July 25, 2023 by MissionIR

With experts predicting that nickel metal will play a key role in the 2023 battery-grade market (https://ibn.fm/e8Ky4), Canada Nickel Company (TSX.V: CNC) (OTCQX: CNIKF) appears to be ideally positioned in the growing space. The company just released initial results from … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

MissionIRNewsBreaks — BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) CDMO Services Designed to Meet Needs of Pharmaceutical, Biotechnology Companies of All Sizes

Posted on July 24, 2023 by MissionIR

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company recently showcased its boutique end-to-end contract development and manufacturing organization (“CDMO”) services and … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) KAP Deploys K5 to San Diego Residential Community

Posted on July 24, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that Knightscope Authorized Partner (“KAP”) JDS Security deployed its first of four K5 ASRs at a multifamily apartment community in San … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Leveraging Updated Implementation Strategy for Los Azules Project

Posted on July 24, 2023 by MissionIR

McEwen Mining (NYSE: MUX) (TSX: MUX), an asset-rich diversified gold and copper producer that owns 52% of McEwen Copper, recently released the results of an updated Preliminary Economic Assessment (“2023 PEA”) on the 100% McEwen Copper-owned Los Azules Project in … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment